A new machine-learning algorithm is assisting researchers to determine which existing drugs can be repurposed effectively for other conditions.
Focusing on genes associated with psychiatric and neurological disorders, and drugs approved for use in other diseases, a new AI system can increase the effectiveness of drug repurposing.
